$Cognition Therapeutics (CGTX.US)$ Cognition Therapeutics Publishes Research Supporting the Potential of Zervimesine in Dry AMD 9 minutes ago, 4:30 AM PST Via GlobeNewswire CGTX Share PURCHASE, N.Y., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ:CGTX), a clinical stage company developing neurodegenerative disease candidates, (the "Company" or "Cognition") announced the publication of a manuscript reviewing recent work supporting the potential of zervimesine (CT1812),...
Cognition Therapeutics Stock Forum
Can Cognition's Zervimesine Tackle Dry AMD? New Research Reveals Promising Cellular Rescue
Cognition Therapeutics Publishes Research Supporting the Potential of Zervimesine in Dry AMD
9 minutes ago, 4:30 AM PST
Via GlobeNewswire
CGTX
Share
PURCHASE, N.Y., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ:CGTX), a clinical stage company developing neurodegenerative disease candidates, (the "Company" or "Cognition") announced the publication of a manuscript reviewing recent work supporting the potential of zervimesine (CT1812),...
No comment yet